Alkermes

ALKSNasdaq Ireland Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$7.412 B

$44.18 +1.82%

Close of 21 Sept 2026

Revenue

$1.48B

#1305 by revenue

Earnings

$241.7M

#921 by earnings

Shares outstanding

167,763,272

Latest filing cover page

P/E ratio

30.7

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#41Spyre TherapeuticsSYRE$8.11B
#42Ionis PharmaceuticalsIONS$7.46B
#43AlkermesALKS$7.41B
#44Amneal PharmaceuticalsAMRX$7.02B
#45Belite BioBLTE$6.98B

What if Alkermes were worth as much as…

Open the what-if tool →

Gold $30.3T

$180,456.98

Per share 4,085× higher

Bitcoin $1.72T

$10,251.37

Per share 232× higher

Nvidia $5.48T

$32,664.23

Per share 739× higher

Or at a round number

$10.0B $20.0B $50.0B $100.0B

Where these numbers come from

Share counts and financials for Alkermes are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.